Based on the genetic profile of tumor tissue samples, patients with different CCNE1 amplification statuses had indistinguishable PFS (P = 0.94; Fig. 3A), while patients with CCNE1 amplification tended to have a worse OS (P = 0.055; Fig. 3B). Here, CCNE1 is linked to neoplasm.